Prognosis
Lunesta, Dayvigo Favored Over Ambien for Insomnia in UK Study
Ambien and Lunesta
Photographer: JB Reed/Bloomberg
This article is for subscribers only.
UK researchers who analyzed decades of data found that two drugs sold under the brand names Lunesta and Dayvigo appear to perform better than others, including Ambien, in treating insomnia.
A University of Oxford study, described as the largest of its kind, evaluated findings from more than 150 trials in a bid to help doctors and patients find the most appropriate treatment for insomnia. As much as 20% of the population regularly has problems sleeping, which increases the risks of heart disease, obesity, diabetes, depression, anxiety and suicide, the authors said.